Transcatheter aortic valve implantation (TAVI) has evolved as a routine therapeutic option to treat elderly and high-risk patients with symptomatic…

Coronary artery disease (CAD) is the leading cause of morbidity and mortality worldwide. The pathogenesis of CAD relates to the presence of…

This review focuses on describing new generations of drug-eluting stents (DES) based on the use of novel stent platforms, coatings, and carrier systems…

Cardiovascular disease is a major cause of morbidity and mortality, especially in developed countries. Currently, when suitable autologous tissue is…

Despite improvements in stent platform, polymer, and drug elution, the permanent metallic stents have significant limitations as they distort vessel…

Percutaneous intervention of coronary bifurcation lesions continues to challenge interventional cardiologists. Nonetheless, the past decade has seen an…

Approximately 20% of percutaneous coronary interventions (PCIs) are performed to treat coronary bifurcations. PCIs in bifurcation lesions have been…

Since the introduction of transcatheter aortic valve implantation (TAVI) 12 years ago, the treatment options for severe, symptomatic aortic valve…

For these patients, transcatheter-based therapies represent an attractive option. While most interventional techniques are still in experimental or early…

Coronary chronic total occlusions (CTOs) are frequently encountered in clinical practice, and their presence influences management decisions; patients…